Drug intelligence / Profile preview

PreVID

Development stage: Unknown
Lead developer: PreEmptive Meds
Administration: Oral

Overview

**PreVID** is a proprietary oral nutraceutical supplement developed by PreEmptive Meds for immune support in people considered at risk of viral infectious diseases. The sachet formulation contains nano-curcumin, piperine, zinc, vitamin C, and vitamin D in an emulsified and micro-encapsulated delivery system intended to enhance nutrient absorption. It is marketed as a vegan, sugar-free, and gluten-free consumer supplement rather than as an approved pharmaceutical antiviral or vaccine.

Brand names: PreVID

Beyond the preview

Go deeper on PreVID.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PreVID.

Explore the full profile